Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans

Human Genetics

Volumn 127, Issue 1, 2010, Pages 65-73

  Velez, Digna Rosa ^a   Wejse, Christian ^a,h,i   Stryjewski , Martin E ^d   Abbate, Eduardo ^e   Hulme, William F ^a   Myers, Jamie L ^a   Estevan, Rosa ^e   Patillo, Sara G ^c   Olesen, Rikke ^a,h   Tacconelli, Alessandra ^f,g   Sirugo, Giorgio ^f,g   Gilbert, John R ^a   Hamilton, Carol D ^b,c   Scott, William K ^a,j  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b FAMILY HEALTH INTERNATIONAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d CEMIC   (Argentina)

^e HOSPITAL F J MUÑIZ   (Argentina)

^f FATEBENEFRATELLI HOSPITAL   (Italy)

^g UNIVERSITY OF ROME TOR VERGATA   (Italy)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁱ Danish Epidemiology Science Centre   (United States)

^j NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TUBERCULOSTATIC AGENT; TLR2 PROTEIN, HUMAN;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GUINEA-BISSAU; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NEGRO; POPULATION GENETICS; PRIORITY JOURNAL; RACE DIFFERENCE; CLINICAL TRIAL; ETHNOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MULTICENTER STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GUINEA-BISSAU; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 9; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 77449122899     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-009-0741-7     Document Type: Article

References (34)

1. Abecasis GR, Cookson WO (2000) GOLD-graphical overview of linkage disequilibrium. Bioinformatics 16:182-183
2. Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2:675-680 (Pubitemid 32747155)
3. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783-801
4. Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, Rutschmann S, Du X, Hoebe K (2006) Genetic analysis of host resistance: toll-like receptor signaling and immunity at large. Annu Rev Immunol 24:353-389
5. Bowdish DM, Sakamoto K, Kim MJ, Kroos M, Mukhopadhyay S, Leifer CA, Tryggvason K, Gordon S, Russell DG (2009) MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 5:e1000474
6. Branger J, Leemans JC, Florquin S, Weijer S, Speelman P, Van Der PT (2004) Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice. Int Immunol 16:509-516 (Pubitemid 38313159)
7. Buwitt-Beckmann U, Heine H, Wiesmuller KH, Jung G, Brock R, Akira S, Ulmer AJ (2005) Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur J Immunol 35:282-289
8. Buwitt-Beckmann U, Heine H, Wiesmuller KH, Jung G, Brock R, Akira S, Ulmer AJ (2006) TLR1- and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem 281:9049-9057
9. Comstock G (1978) Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 117:621-624
10. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572
11. Fremond CM, Yeremeev V, Nicolle DM, Jacobs M, Quesniaux VF, Ryffel B (2004) Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Invest 114:1790-1799
12. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225-2229
13. Greenwood CMT, Fujiwara M, Boothroyd LJ, Miller MA, Frappier D, Fanning EA, Schurr E, MorganK (2000) Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet 67:405-416
14. Hancock DB, Martin ER, Li YJ, Scott WK (2007) Methods for interaction analyses using family-based case-control data: conditional logistic regression versus generalized estimating equations. Genet Epidemiol 31:883-893
15. Hill PC, Brookes RH, Fox A, Fielding K, Jeffries DJ, Jackson-Sillah D, Lugos MD, Owiafe PK, Donkor SA, Hammond AS, Otu JK, Corrah T, Adegbola RA, McAdam KP (2004) Large-scale evaluation of enzyme-linked immunospot assay and skin test fordiagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 38:966-973
16. Huang LY, Ishii KJ, Akira S, Aliberti J, Golding B (2005) Th1-like cytokine induction by heat-killed Brucella abortus is dependent on triggering of TLR9. J Immunol 175:3964-3970
17. Ma X, Liu Y, Gowen BB, Graviss EA, Clark AG, Musser JM (2007) Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS ONE 2:e1318
18. Misch EA, Hawn TR (2008) Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci (Lond) 114: 347-360
19. Morr M, Takeuchi O, Akira S, Simon MM, Muhlradt PF (2002) Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur J Immunol 32:3337-3347
20. Newport MJ, Allen A, Awomoyi AA, Dunstan SJ, McKinney E, Marchant A, Sirugo G (2004) The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia. Tuberculosis (Edinb) 84:347-352
21. Noguchi E, Nishimura F, Fukai H, Kim J, Ichikawa K, Shibasaki M, Arinami T (2004) An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 34:177-183
22. Okusawa T, Fujita M, Nakamura J, Into T, Yasuda M, Yoshimura A, Hara Y, Hasebe A, Golenbock DT, Morita M, Kuroki Y, Ogawa T, Shibata K (2004) Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6. Infect Immun 72:1657-1665
23. Olesen R, Wejse C, Velez DR, Bisseye C, Sodemann M, Aaby P, Rabna P, Worwui A, Chapman H, Diatta M, Adegbola RA, Hill PC, Ostergaard L, Williams SM, Sirugo G (2007) DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun 8:456-467
24. Skamene E, Schurr E, Gros P (1998) Infection Genomics: Nramp1 as major determinant of natural resistance to intracellular infections. Annu Rev Med 49:275-287
25. Sousa AO, Salem JI, Lee FK, Vercosa MC, Cruaud P, Bloom BR, Lagrange PH, Hugo DL (1997) An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci USA 94:13227-13232
26. StataCorp (2008) Stata Statistical Software: Release 9
27. Suzuki Y, Wakita D, Chamoto K, Narita Y, Tsuji T, Takeshima T, Gyobu H, Kawarada Y, Kondo S, Akira S, Katoh H, Ikeda H, Nishimura T (2004) Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity. Cancer Res 64:8754-8760
28. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335-376
29. Takeshita F, Leifer CA, Gursel I, Ishii KJ, Takeshita S, Gursel M, Klinman DM (2001) Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 167:3555-3558
30. The International HapMap Consortium (2003) The International HapMap Project. Nature 426:789-796
31. Velez, Hulme WF, Weinberg FB, Levesque M, Abbato E, Estevan R, Patillow SG, Gilbert JR, Hamilton CD, Scott WK (2009) Association of SLC11A1 and pulmonary tuberculosis and interactions with NOS2A/TLR2 in African-Americans and Caucasians (submitted)
32. Wang F, Tahara T, Arisawa T, Shibata T, Nakamura M, Fujita H, Iwata M, Kamiya Y, Nagasaka M, Takahama K, Watanabe M, Hirata I, Nakano H (2007) Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis. J Gastroenterol Hepatol 22:925-929
33. WHO Website (2008) World Health Organization. Programs and projects. Tuberculosis. The Stop TB Strategy
34. World Health Organization (2004) Tuberculosis. Fact Sheet Number 104, Revised March 2004 edition